Braveheart Bio

Braveheart Bio is a late clinical-stage biotechnology company focused on developing novel therapeutics for hypertrophic cardiomyopathy and related conditions. The company is supported by prominent life science investors, including Andreessen Horowitz (a16z Bio + Health), Forbion, OrbiMed, Enavate Sciences (a platform of Patient Square Capital), and Frazier Life Sciences. Its lead candidate, BHB-1893, is currently advancing through late-stage clinical development with the aim of establishing a new standard of care. Braveheart Bio operates within the biotechnology research industry and employs more than 30 people dedicated to advancing its clinical programs.

• 

  Braveheart Bio

  9 days ago

  Associate director/director, medical affairs – publications

  remote, San Francisco, CA, United States

  $175k – $245k/yrFull TimeDirector

  Apply
• 

  Braveheart Bio

  10 days ago

  (senior) director, regulatory affairs cmc

  onsite, San Francisco, CA, United States

  $210k – $305k/yrFull TimeDirector

  Apply
• 

  Braveheart Bio

  16 days ago

  Associate director, clinical science

  remote, San Francisco, CA, United States

  $180k – $240k/yrFull TimeDirector

  Apply
• 

  Braveheart Bio

  24 days ago

  Senior manager, regulatory affairs

  onsite, San Francisco, CA, United States

  $170k – $195k/yrFull TimeSenior (5+ years)

  Apply
• 

  Braveheart Bio

  25 days ago

  Associate director, quality (clinical)

  onsite, San Francisco, CA, United States

  $175k – $210k/yrFull TimeDirector

  Apply

Hiring activity at Braveheart Bio